Actor
GaDia
![](/app/uploads/2018/07/icon-line-bicolor.png)
Developing an innovative, patented rapid in vitro diagnostic (IVD) test to detect nosocomial diseases.
More specifically, the aim is to develop a new rapid Point-Of-Care (POC) predictive diagnostic test to discriminate healthcare-acquired fungal infections from other causes of infections.
Specialties
Primary Therapeutic Areas
0. COVID-19
1.0 Therapeutic & Diagnostic
1.00 Antibodies & Anti-infectious
1.5 Medical Technology
1.52 Diagnostic & In-Vitro Device
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
![GaDia](https://bioalps.org/app/uploads/2020/10/201006_SERIE-COVID_Testimonials_GaDia_Logo_pantone540c-021c_1200x800px.png)
Visit website
Domains
COVID-Areas, Infectious Diseases
Main sector
Medtech
Contact
Route de l'Ile-aux-Bois 1A
1870 Monthey / VS
796328447